COMPANY

GRI Bio

HQ: La Jolla, CA source · gribio.com ↗ · West Coast

GRI Bio (NASDAQ: GRI) is a clinical-stage biopharmaceutical company. From company website Source · Oct 12, 2026

Keywords: biopharmaceutical

Profile checked Oct 10, 2026

Timeline

Dec 12, 2025 Raise Follow-on offering: $8M (total, as published), announced Dec 12, 2025. Source: SEC filing. source ↗
Apr 2, 2025 Raise Follow-on offering: $5M (total, as published), announced Apr 2, 2025. Source: company release on GlobeNewswire. source ↗

Raised: $13.0M. Last 2 years.

Dec 12, 2025 Follow-on offering: $8M (total, as published), announced Dec 12, 2025. Source: SEC filing. source ↗
Apr 2, 2025 Follow-on offering: $5M (total, as published), announced Apr 2, 2025. Source: company release on GlobeNewswire. source ↗

Form D raises come from the company’s own SEC filing (last 2 years).

2024-10-25 Raise Private raise (SEC Form D): $762K sold; issuer “GRI BIO, Inc.”. Verified from the SEC filing. SEC filing ↗